Specialty Research and Innovation
-
Featured
Favipiravir to Treat COVID-19: Q&A with Boris Juelg, MD, PhD
Boris Juelg, MD, PhD, an attending physician in the Division of Infectious Diseases at Massachusetts General Hospital and an assistant professor at Harvard Medical School, explains what is currently known about the drug favipiravir and why he is excited about its potential to treat COVID-19 patients.
-
Featured
Mass General Launching Randomized, Controlled Trial of Tocilizumab for COVID-19
Tocilizumab, a monoclonal antibody that blocks IL-6 already approved in the U.S., might be effective against COVID-19, researchers from Massachusetts General Hospital believe.
-
Featured
Using Chloroquine to Treat COVID-19: Q&A with Raghu Chivukula, MD, PhD
Raghu Chivukula, MD, PhD, a physician-scientist in the Division of Pulmonary and Critical Care Medicine at Massachusetts General Hospital, explains what is currently known about chloroquine and its use to treat COVID-19 patients.
-
Why Pursuing Multiple Vaccines May Be the Best Way to End the COVID-19 Pandemic
The race to test and approve a vaccine for the SARS-CoV-2 virus is moving quickly, with over 100 vaccines now in development.The goal is to identify and accelerate multiple promising candidates into production. Here, Mass General investigators highlight the strengths and weaknesses of the various approaches and what the next key steps needed are to develop and distribute a new vaccine quickly.
-
Medical Grand Rounds: COVID-19 and Health Equity: A Focus on Health System Solutions to Magnified Inequities
On July 9, 2020, the Department of Medicine held a virtual Grand Rounds presentation related to COVID-19. Joseph Betancourt, MD, MPH, vice president and chief equity and inclusion officer at Mass General, Aisha James, MD, MS, primary care physician, as well as experts from the Boston medical community, talked about COVID-19 and health equity.
-
COVID-19 Prevention in the Urological Community
Mass General urologist Adam Feldman, MD, MPH, discussed some key takeaways from Anthony S. Fauci, MD's address at the American Urologic Association's 2020 Live Virtual Experience, including the impact that COVID-19 has had on urologic care.
Research and Innovation contributors
-
Andrew T. Chan, MD, MPH
Professor of Medicine, Harvard Medical School, Director for Cancer Epidemiology, Mass General Cancer Center, Chief, Clinical and Translational Epidemiology Unit, Department of Medicine
Recent Article
Aspirin Doubles Risk for Upper GI Bleeding Events in Older Adults
-
Benjamin David Medoff, MD
Chief, Division of Pulmonary and Critical Care, Principal Investigator, Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital
Recent Article
Medical Grand Rounds: Pathogenesis and Management of Respiratory Failure in COVID-19: What We Know So Far -
Boris D. Juelg, MD, PhD
Attending Physician, Division of Infectious Diseases, Massachusetts General Hospital, Assistant Professor, Harvard Medical School
Recent Article
Favipiravir to Treat COVID-19: Q&A with Boris Juelg, MD, PhD
-
Bryan Hayes, PharmD, DABAT, FAACT, FASHP
Assistant Professor of Emergency Medicine, Harvard Medical School, Senior Attending Pharmacist, Emergency Medicine and Toxicology, Massachusetts General Hospital
Recent Article
The Use of NSAIDs in COVID-19 Patients: Q&A with Bryan D. Hayes, PharmD -
Charles Corey Hardin, MD, PhD
Physician, Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, Associate Professor of Medicine, Harvard Medical School, Physician Investigator, Pulmonary, Mass General Research Institute
Recent Article
No Evidence to Support Novel Mechanism of Hypoxemia in COVID-19
-
David M. Dudzinski, MD
Intensive Care Cardiologist, Massachusetts General Hospital, Director, Cardiac Intensive Care Unit, Associate Editor, Case Records of the MGH
Recent Article
International Perspectives: Optimizing Cardiac Critical Care During the COVID-19 Pandemic
-
Elizabeth Louise Hohmann, MD
Staff Physician, Infectious Diseases Division, Massachusetts General Hospital, Chair and Physician Director, Partners Human Research Committees
Recent Article
Early Results of Remdesivir Trial Are Promising, But More Research Needed -
Gregory D. Lewis, MD
Section Head, Heart Failure, Director, Cardiopulmonary Exercise Testing Laboratory, Medical Director, Cardiology ICU and Mechanical Circulatory Support Program
Recent Article
Exercise Testing Can Unmask Abnormal Pulmonary Vascular Responses in Patients with Chronic Dyspnea
-
Guillermo (Gary) Tearney, MD, PhD
Professor of Pathology, Harvard Medical School, Pathologist/Physicist, Massachusetts General Hospital, Faculty, Wellman Center for Photomedicine
Recent Article
Epithelial Thickness Proposed as Biomarker to Guide Treatment of Barrett's Esophagus -
Lorenzo Berra, MD
Medical Director, Respiratory Care, Massachusetts General Hospital
Recent Article
Review: How to Make ICUs More Geriatrics-friendly
-
Louise C. Ivers, MD
Executive Director of the Mass General Center for Global Health, Associate Physician in the Division of Infectious Diseases
Recent Article
Medical Grand Rounds: COVID-19 in Low-Resourced Settings—Reaching for Global Health Equity -
Raghu Chivukula, MD, PhD
Physician-Scientist, Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital
Recent Article
Identification of Novel Bronchiectasis Syndrome Has Implications for Other Respiratory Diseases
-
Tomas G. Neilan, MD, MPH
Director, Cardio-Oncology Program, Co-Director, Cardiac MR PET CT Program
Recent Article
Cardiac Injury and Cardiovascular Events Are Common After CAR T Therapy
-
Vicki Jackson, MD
Chief, Palliative Care, Massachusetts General Hospital
Recent Article
Improving "Webside Manner" for Virtual Visits About Serious Illness
